From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?

about

From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?

Item

http://www.wikidata.org/entity/Q39041541

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

From chemotherapy to target th ...... of NSCLC: a durable marriage?

@en

From chemotherapy to target th ...... of NSCLC: a durable marriage?

@nl

type

Item

label

From chemotherapy to target th ...... of NSCLC: a durable marriage?

@en

From chemotherapy to target th ...... of NSCLC: a durable marriage?

@nl

prefLabel

From chemotherapy to target th ...... of NSCLC: a durable marriage?

@en

From chemotherapy to target th ...... of NSCLC: a durable marriage?

@nl

P1476

From chemotherapy to target th ...... of NSCLC: a durable marriage?

@en

P2093

Elvio Russi

http://www.w3.org/2001/XMLSchema#string

Marco Trovò

http://www.w3.org/2001/XMLSchema#string

Niccolò Giaj-Levra

http://www.w3.org/2001/XMLSchema#string

Rolando D'angelillo

http://www.w3.org/2001/XMLSchema#string

Sara Ramella

http://www.w3.org/2001/XMLSchema#string

Stefano Arcangeli

http://www.w3.org/2001/XMLSchema#string

Stefano Maria Magrini

http://www.w3.org/2001/XMLSchema#string

on the behalf of Associazione Italiana Radioterapia Oncologica (AIRO)

http://www.w3.org/2001/XMLSchema#string

P2860

Combining radiation and immunotherapy: a new systemic therapy for solid tumors?

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Ceritinib in ALK-rearranged non-small-cell lung cancer.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

Immunologic correlates of the abscopal effect in a patient with melanoma

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

P304

157-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737140.2017.1273111

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27984919

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

Abielu